Has Justin Morrison, MD received payments from drug or device companies?

Yes. Drug and device makers reported $16,344 in general payments to Justin Morrison, MD across 99 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Justin Morrison, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Justin Morrison, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Justin Morrison, MD

Interventional Cardiology · Columbus, OHNPI 1326467010

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (36.7%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 15 manufacturers reported payments, led by Inari Medical, Inc. at 48.5% of the total. Reporting peaked in 2024 at $10,039 and has fallen 65.5% since, to $3,461 in 2025.

$16,344in general payments, 2019–2025

Across 99 payments — averaging $165.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Inari Medical, Inc.$8K
Boston Scientific$4K
Edwards Lifesciences$2K
Medtronic$882
Penumbra, Inc.$866
Abbott$441
plus $860 from 9 others

$152,058in research payments, 2019–2025

Across 5 payments — averaging $30,412 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Astrazeneca UK Limited$90K
Medtronic$62K

What the payments were for

Consulting fees$1,87511%
Speaking & faculty fees$6,00037%
Travel & lodging$3,23020%
Food & beverage$4,89030%
Education$3502%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Inari Medical, Inc.	16	$7,928
Boston Scientific	21	$3,854
Edwards Lifesciences	13	$1,514
Medtronic(2 entities)	19	$882
Penumbra, Inc.	9	$866
Abbott	9	$441
Philips North America LLC	2	$267
W. L. Gore & Associates, Inc.	1	$129
Endologix LLC	1	$129
Amplitude Vascular Systems, Inc.	1	$122
Bard Peripheral Vascular, Inc.	1	$82
Stryker	2	$55
Novo Nordisk	2	$44
Biotronik Inc.	1	$17
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

FLOWTRIEVER CATHETER, S$7,573
CT THROMBECTOMY SYSTEM KIT$7,573
AVVIGO Guidance System$2,311
Indigo System$444
Edwards SAPIEN 3 Transcatheter Heart Valve$366
Integrity$210
Diamondback Peripheral$174
ELUVIA$151
(6554) Peripheral Vascular Undivided$140
COREVALVE EVOLUT R$140
EnSite Precision Cardiac Mapping System$139
GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis$129
Torus Stent Graft System$129
ENDOCROSS Device$129
FFRangio$128
(5575) Venous Stent Und$127
Penumbra System$119

How this compares

$16,344 in reported general payments places this provider in the 75th percentile of 256 interventional cardiology providers in Ohio.

See all interventional cardiology providers in Ohio →

Medicare billing

Part B allowed, 2024

$99,748

Medicare patients

915

Services billed

1,408

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	60	$50,531
XareltoRivaroxaban	38	$36,678
ClopidogrelClopidogrel Bisulfate	106	$771
Metoprolol Succinate	47	$395
Atorvastatin Calcium	67	$382
Rosuvastatin Calcium	40	$155
Ezetimibe	16	$139
Carvedilol	36	$121
Losartan Potassium	13	$118
Spironolactone	16	$77
Lisinopril	12	$71
Metoprolol Tartrate	12	$63
Amlodipine Besylate	14	$43

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in Columbus

Gary AnselColumbus$3.3M
John CheathamColumbus$1.4M
Carlos Sanchez SotoColumbus$1.1M
Steven YakubovColumbus$907K
Mitchell SilverColumbus$562K
John PhillipsColumbus$410K
Michael JollyColumbus$281K
Timothy SmithColumbus$149K
Christopher HuffColumbus$119K
Joseph CampbellColumbus$114K

See the full list for Ohio →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →